In rats orally administered beLP-K at 1 and 2 mg/kg, the expression levels of MAFbx/atrogin-1, a protein that mediates muscle degradation through the E3-ubiquitin proteasome pathway during DEX-induced sarcopenia, significantly decreased (Figure 10B). This evidence concerns the gene FBXO32 and sarcopenia.